Pieris Pharmaceuticals Company Profile (NASDAQ:PIRS)

About Pieris Pharmaceuticals

Pieris Pharmaceuticals logoPieris Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company's pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-optimized Anticalin to treat anemia. Its Anticalins proteins are a class of low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins typically found in blood plasma and other bodily fluids. It is focused on developing three drug candidates, which include PRS-080, PRS-060 and PRS-300 series. Its PRS-080 is an Anticalin drug candidate targeting hepcidin. The Company's second Anticalin drug candidate, PRS-060, binds to the IL-4 receptor alpha-chain (IL-4RA), thereby inhibiting the actions of IL-4 and IL-13, two cytokines known to be mediators in the inflammatory cascade that causes asthma and other inflammatory diseases. PRS-343 is an Anticalin-based drug candidate.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PIRS
  • CUSIP:
Key Metrics:
  • Previous Close: $1.71
  • 50 Day Moving Average: $1.63
  • 200 Day Moving Average: $1.79
  • 52-Week Range: $1.26 - $3.08
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.90
  • P/E Growth: 0.00
  • Market Cap: $73.63M
  • Outstanding Shares: 43,058,000
  • Beta: 1.66
Profitability:
  • Net Margins: -346.01%
  • Return on Equity: -52.21%
  • Return on Assets: -43.87%
Debt:
  • Current Ratio: 6.85%
  • Quick Ratio: 6.85%
Additional Links:
Companies Related to Pieris Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Pieris Pharmaceuticals (NASDAQ:PIRS) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.33 (387.33% upside)

Analysts' Ratings History for Pieris Pharmaceuticals (NASDAQ:PIRS)
Show:
DateFirmActionRatingPrice TargetDetails
8/5/2016Roth CapitalReiterated RatingBuy$6.00View Rating Details
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$10.00 -> $9.00View Rating Details
12/8/2015Oppenheimer Holdings Inc.Reiterated RatingBuy$8.00 -> $10.00View Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for Pieris Pharmaceuticals (NASDAQ:PIRS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2016        
8/10/2016Q216($0.15)($0.14)$1.07 millionViewN/AView Earnings Details
5/12/2016Q116($0.12)($0.10)ViewN/AView Earnings Details
3/23/2016Q415($0.12)($0.07)$3.27 million$2.14 millionViewN/AView Earnings Details
11/12/2015Q315($0.11)($0.10)ViewN/AView Earnings Details
8/13/2015Q215($0.14)($0.12)$160.24 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Pieris Pharmaceuticals (NASDAQ:PIRS)
Current Year EPS Consensus Estimate: $-0.55 EPS
Next Year EPS Consensus Estimate: $-0.59 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.03$0.03$0.03
Q2 20162($0.16)($0.12)($0.14)
Q3 20162($0.14)($0.12)($0.13)
Q4 20162($0.14)($0.12)($0.13)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Pieris Pharmaceuticals (NASDAQ:PIRS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Pieris Pharmaceuticals (NASDAQ:PIRS)
Insider Ownership Percentage: 2.43%
Institutional Ownership Percentage: 45.79%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/14/2016Louis MatisSVPBuy10,000$1.70$17,000.00View SEC Filing  
6/13/2016Darlene M Deptula-HicksCFOBuy5,000$1.66$8,300.00View SEC Filing  
6/13/2016Stephen S YoderCEOBuy6,000$1.68$10,080.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Pieris Pharmaceuticals (NASDAQ:PIRS)
DateHeadline
News IconPenny Stock Investors are Growing Curious About Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) - Duncan Research (NASDAQ:PIRS)
www.duncanindependent.com - September 27 at 6:40 PM
News IconShares Spotted Gapping HIgher Pre-Bell: Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) - Post News (NASDAQ:PIRS)
www.kentuckypostnews.com - September 27 at 6:40 PM
News IconPre-Movers Stocks In Imitation: Williams Companies, Inc. (NYSE:WMB), Pieris Pharmaceuticals, Inc. (PIRS), Turtle ... - Street Wise Report (press release) (blog) (NASDAQ:PIRS)
streetwisereport.com - September 27 at 6:40 PM
streetinsider.com logoPieris Pharma (PIRS) Says It Presented Positive Data for Lead Drug Candidate PRS-343 - StreetInsider.com (NASDAQ:PIRS)
www.streetinsider.com - September 27 at 6:40 PM
nasdaq.com logoPieris Pharma Jumps 13% - Unveils Positive Data on Cancer Immunotherapeutic Drug Candidate PRS-343 (NASDAQ:PIRS)
www.nasdaq.com - September 27 at 11:22 AM
streetinsider.com logoPieris Pharma (PIRS) Says It Presented Positive Data for Lead Drug Candidate PRS-343 (NASDAQ:PIRS)
www.streetinsider.com - September 27 at 11:22 AM
finance.yahoo.com logo5:16 pm Pieris Pharmaceuticals presents 'positive' data for its bispecific drug candidate, PRS-343 (NASDAQ:PIRS)
finance.yahoo.com - September 27 at 11:22 AM
finance.yahoo.com logoPieris Pharmaceuticals Presents Positive Data for Its … (NASDAQ:PIRS)
finance.yahoo.com - September 26 at 6:50 PM
finance.yahoo.com logoPieris Pharmaceuticals Presents Positive Data for Its Lead Bispecific Drug Candidate, PRS-343, at the 2016 CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference (NASDAQ:PIRS)
finance.yahoo.com - September 26 at 6:50 PM
4-traders.com logoPieris Pharmaceuticals : Appoints Christopher Kiritsy to Its Board of Directors (NASDAQ:PIRS)
www.4-traders.com - September 24 at 11:12 AM
News IconUnder the Microscope, Zeroing in at Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) - Duncan Research (NASDAQ:PIRS)
www.duncanindependent.com - September 23 at 6:17 PM
News IconActive Runners in Thrust: Tesla Motors (NASDAQ:TSLA), Pieris Pharmaceuticals (NASDAQ:PIRS), Primoris Services ... - Seneca Globe (NASDAQ:PIRS)
www.senecaglobe.com - September 23 at 6:17 PM
marketwired.com logoPieris Pharmaceuticals Appoints Christopher Kiritsy to Its Board of Directors (NASDAQ:PIRS)
www.marketwired.com - September 22 at 6:27 PM
finance.yahoo.com logoPieris Pharmaceuticals Appoints Christopher Kiritsy to Its Board of Directors - Yahoo Finance (NASDAQ:PIRS)
finance.yahoo.com - September 22 at 11:36 AM
News IconPenny Stock Investors Keen on Shares of Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) - Duncan Research (NASDAQ:PIRS)
www.duncanindependent.com - September 21 at 6:23 PM
News IconUnder the Microscope: Getting a Closer Look at Shares of Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) - Duncan Research (NASDAQ:PIRS)
www.duncanindependent.com - September 19 at 6:42 PM
News IconStock Update, a Closer Look at Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) - Duncan Research (NASDAQ:PIRS)
www.duncanindependent.com - September 16 at 10:20 AM
News IconKeen Investors Narrowing Their Focus on Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) - Duncan Research (NASDAQ:PIRS)
www.duncanindependent.com - September 15 at 10:19 AM
News IconPenny Stock Investors Highly Curious in Shares of Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) - Duncan Research (NASDAQ:PIRS)
www.duncanindependent.com - September 13 at 11:40 AM
News IconThe Sell-side Consensus is in on Pieris Pharmaceuticals Inc (NASDAQ:PIRS); Earnings & Target Updates - National Daily Press (NASDAQ:PIRS)
www.nationaldailypress.com - September 10 at 6:02 PM
finance.yahoo.com logoPieris Pharmaceuticals Announces Presentation of Data for Its Lead IO Bispecific Program, PRS-343, at the 2016 CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference (NASDAQ:PIRS)
finance.yahoo.com - September 7 at 10:19 AM
finance.yahoo.com logoPieris Pharmaceuticals to Present at Rodman & Renshaw 18th Annual Global Investor Conference (NASDAQ:PIRS)
finance.yahoo.com - September 1 at 6:44 PM
News IconHow is the Crowd Rating Shares of Pieris Pharmaceuticals Inc (NASDAQ:PIRS)? - Post News (NASDAQ:PIRS)
www.kentuckypostnews.com - August 24 at 6:36 PM
News IconStock Tracking Lower for the Quarter: Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) - Post News (NASDAQ:PIRS)
www.kentuckypostnews.com - August 21 at 10:50 AM
finance.yahoo.com logoPIERIS PHARMACEUTICALS, INC. Financials (NASDAQ:PIRS)
finance.yahoo.com - August 19 at 6:45 PM
capitalcube.com logoPieris Pharmaceuticals, Inc. :PIRS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:PIRS)
www.capitalcube.com - August 12 at 6:58 PM
finance.yahoo.com logoPIRS: Development of Multiple Anticalin® Products Continues… (NASDAQ:PIRS)
finance.yahoo.com - August 12 at 6:58 PM
biz.yahoo.com logoPIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements (NASDAQ:PIRS)
biz.yahoo.com - August 11 at 10:05 AM
sg.finance.yahoo.com logoPieris Pharmaceuticals reports 2Q loss (NASDAQ:PIRS)
sg.finance.yahoo.com - August 10 at 7:18 PM
kcregister.com logoPieris Pharmaceuticals, Inc. (NASDAQ:PIRS) rose 1.39%, The Spectranetics Corporation (NASDAQ:SPNC), General ... - KC Register (NASDAQ:PIRS)
www.kcregister.com - August 1 at 11:32 AM
finance.yahoo.com logoPieris Pharmaceuticals to Host Second Quarter 2016 Investor Call and Corporate Update on August 11, 2016 (NASDAQ:PIRS)
finance.yahoo.com - August 1 at 8:00 AM
marketwired.com logoPieris Pharmaceuticals Appoints Julian Adams, Ph.D., to Its Board of Directors - Marketwired (press release) (NASDAQ:PIRS)
www.marketwired.com - July 27 at 7:13 PM
biz.yahoo.com logoPIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and (NASDAQ:PIRS)
biz.yahoo.com - July 26 at 9:23 AM
News IconChecking in on Stock Volatility for: Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) - Engelwood Daily (NASDAQ:PIRS)
www.engelwooddaily.com - July 22 at 6:42 PM
News IconPieris Pharmaceuticals Inc (NASDAQ:PIRS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:PIRS)
www.engelwooddaily.com - July 22 at 6:42 PM
News IconPieris Pharmaceuticals Incorporated (NASDAQ:PIRS) Shorted Shares Increased 43.71% After Market Selling - Consumer Eagle (NASDAQ:PIRS)
www.consumereagle.com - July 22 at 6:42 PM
news.cmlviz.com logoPieris Pharmaceuticals Inc Stock Technicals at Critical Inflection Point - CML News (NASDAQ:PIRS)
news.cmlviz.com - July 21 at 9:43 AM
News IconEquity Roundup: Stock Performance Focus on Pieris Pharmaceuticals Inc (NASDAQ:PIRS) - Press Telegraph (NASDAQ:PIRS)
presstelegraph.com - July 21 at 9:43 AM
News IconStock Focus: Following Analyst Expectations on Shares of Pieris Pharmaceuticals Inc (NASDAQ:PIRS) - TGP (NASDAQ:PIRS)
telanaganapress.com - July 20 at 9:41 AM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Pieris Pharmaceuticals Inc (NASDAQ:PIRS) - TGP (NASDAQ:PIRS)
telanaganapress.com - July 20 at 9:41 AM
News IconPieris Pharmaceuticals Incorporated (NASDAQ:PIRS) Sellers Covered 15.84% of Their Shorts - Consumer Eagle (NASDAQ:PIRS)
www.consumereagle.com - July 19 at 6:38 AM
kcregister.com logoWoodward, Inc. (NASDAQ:WWD) Fell -0.32%: Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), Nippon Telegraph and ... - KC Register (NASDAQ:PIRS)
www.kcregister.com - July 15 at 5:53 PM
News IconTrading Performance and Target Watch for Pieris Pharmaceuticals Inc (NASDAQ:PIRS) - Press Telegraph (NASDAQ:PIRS)
presstelegraph.com - July 15 at 11:58 AM
News IconAnalyst Target and Average Rating Watch: Pieris Pharmaceuticals Inc (NASDAQ:PIRS) - Press Telegraph (NASDAQ:PIRS)
presstelegraph.com - July 15 at 11:58 AM
News IconPieris Pharmaceuticals Inc (NASDAQ:PIRS) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:PIRS)
www.engelwooddaily.com - July 15 at 11:58 AM
news.cmlviz.com logoPieris Pharmaceuticals Inc Stock Momentum at Critical Inflection Point - CML News (NASDAQ:PIRS)
news.cmlviz.com - July 11 at 6:50 PM
News IconStock Rating Watch and Earnings Insight for Pieris Pharmaceuticals Inc (NASDAQ:PIRS) - Press Telegraph (NASDAQ:PIRS)
presstelegraph.com - July 11 at 6:50 PM
News IconIncreased Volatility on Shares of: Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) - Engelwood Daily (NASDAQ:PIRS)
www.engelwooddaily.com - July 8 at 6:51 PM
News IconCan Pieris Pharmaceuticals Inc (NASDAQ:PIRS) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:PIRS)
www.engelwooddaily.com - July 8 at 6:51 PM
News IconCompany Stock Focus for Pieris Pharmaceuticals Inc (NASDAQ:PIRS): Which Way Will Shares Head? - Press Telegraph (NASDAQ:PIRS)
presstelegraph.com - July 8 at 6:51 PM

Social

Pieris Pharmaceuticals (NASDAQ:PIRS) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff